Fingerprint
Dive into the research topics of 'Updated safety of midostaurin plus chemotherapy in newly diagnosed FLT3 mutation–positive acute myeloid leukemia: the RADIUS-X expanded access program'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically